Abstract
The F-box protein Fbxw7 mediates the ubiquitylation and consequent degradation of proteins that regulate cell cycle progression, including cyclin E, c-Myc, c-Jun and Notch. Moreover, certain human cancer cell lines harbor loss-of-function mutations in FBXW7 that result in excessive accumulation of Fbxw7 substrates, implicating Fbxw7 in tumor suppression. To elucidate the physiological function of Fbxw7, we conditionally ablated Fbxw7 in mouse embryonic fibroblasts (MEFs). Unexpectedly, loss of Fbxw7 induced cell cycle arrest and apoptosis that were accompanied by abnormal accumulation of the intracellular domain of Notch1 (NICD1). Forced expression of NICD1 in wild-type MEFs recapitulated the phenotype of the Fbxw7-deficient (Fbxw7Δ/Δ) MEFs. Conversely, deletion of Rbpj normalized the phenotype of Fbxw7Δ/Δ MEFs, indicating that this phenotype is dependent on the Notch1–RBP-J signaling pathway. Deletion of the p53 gene prevented cell cycle arrest but not the induction of apoptosis in Fbxw7Δ/Δ cells. These observations suggest that Fbxw7 does not function as an oncosuppressor in MEFs. Instead, it promotes cell cycle progression and cell survival through degradation of Notch1, with loss of Fbxw7 resulting in NICD1 accumulation, cell cycle arrest and apoptosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Akhoondi S, Sun D, von der Lehr N, Apostolidou S, Klotz K, Maljukova A et al. (2007). FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res 67: 9006–9012.
Artavanis-Tsakonas S, Rand MD, Lake RJ . (1999). Notch signaling: cell fate control and signal integration in development. Science 284: 770–776.
Blackwood EM, Kretzner L, Eisenman RN . (1992). Myc and Max function as a nucleoprotein complex. Curr Opin Genet Dev 2: 227–235.
Foltz DR, Santiago MC, Berechid BE, Nye JS . (2002). Glycogen synthase kinase-3β modulates notch signaling and stability. Curr Biol 12: 1006–1011.
Fryer CJ, White JB, Jones KA . (2004). Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol Cell 16: 509–520.
Fujii Y, Yada M, Nishiyama M, Kamura T, Takahashi H, Tsunematsu R et al. (2006). Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation. Cancer Sci 97: 729–736.
Guentchev M, McKay RD . (2006). Notch controls proliferation and differentiation of stem cells in a dose-dependent manner. Eur J Neurosci 23: 2289–2296.
Gupta-Rossi N, Le Bail O, Gonen H, Brou C, Logeat F, Six E et al. (2001). Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor. J Biol Chem 276: 34371–34378.
Han H, Tanigaki K, Yamamoto N, Kuroda K, Yoshimoto M, Nakahata T et al. (2002). Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision. Int Immunol 14: 637–645.
Huang Q, Raya A, DeJesus P, Chao SH, Quon KC, Caldwell JS et al. (2004). Identification of p53 regulators by genome-wide functional analysis. Proc Natl Acad Sci USA 101: 3456–3461.
Hubbard EJ, Wu G, Kitajewski J, Greenwald I . (1997). sel-10, a negative regulator of lin-12 activity in Caenorhabditis elegans, encodes a member of the CDC4 family of proteins. Genes Dev 11: 3182–3193.
Kato H, Sakai T, Tamura K, Minoguchi S, Shirayoshi Y, Hamada Y et al. (1996). Functional conservation of mouse Notch receptor family members. FEBS Lett 395: 221–224.
Kitagawa M, Hatakeyama S, Shirane M, Matsumoto M, Ishida N, Hattori K et al. (1999). An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of β-catenin. EMBO J 18: 2401–2410.
Koepp DM, Schaefer LK, Ye X, Keyomarsi K, Chu C, Harper JW et al. (2001). Phosphorylation-dependent ubiquitination of cyclin E by the SCF(Fbw7) ubiquitin ligase. Science 294: 173–177.
Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S et al. (1992). Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257: 1689–1694.
Loeb KR, Kostner H, Firpo E, Norwood T, Tsuchiya KD, Clurman BE et al. (2005). A mouse model for cyclin E-dependent genetic instability and tumorigenesis. Cancer Cell 8: 35–47.
Lopez-Nieva P, Santos J, Fernandez-Piqueras J . (2004). Defective expression of Notch1 and Notch2 in connection to alterations of c-Myc and Ikaros in γ-radiation-induced mouse thymic lymphomas. Carcinogenesis 25: 1299–1304.
Mao JH, Perez-Losada J, Wu D, Delrosario R, Tsunematsu R, Nakayama KI et al. (2004). Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene. Nature 432: 775–779.
Mo JS, Kim MY, Han SO, Kim IS, Ann EJ, Lee KS et al. (2007). Integrin-linked kinase controls Notch1 signaling by down-regulation of protein stability through Fbw7 ubiquitin ligase. Mol Cell Biol 27: 5565–5574.
Moberg KH, Bell DW, Wahrer DC, Haber DA, Hariharan IK . (2001). Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines. Nature 413: 311–316.
Morita S, Kojima T, Kitamura T . (2000). Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 7: 1063–1066.
Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N et al. (1996). Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85: 707–720.
Nakayama KI, Nakayama K . (2006). Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer 6: 369–381.
Nateri AS, Riera-Sans L, Da Costa C, Behrens A . (2004). The ubiquitin ligase SCF(Fbw7) antagonizes apoptotic JNK signaling. Science 303: 1374–1378.
Nicolas M, Wolfer A, Raj K, Kummer JA, Mill P, van Noort M et al. (2003). Notch1 functions as a tumor suppressor in mouse skin. Nat Genet 33: 416–421.
Oberg C, Li J, Pauley A, Wolf E, Gurney M, Lendahl U . (2001). The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 homolog. J Biol Chem 276: 35847–35853.
O’Neil J, Grim J, Strack P, Rao S, Tibbitts D, Winter C et al. (2007). FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med 204: 1813–1824.
Onoyama I, Tsunematsu R, Matsumoto A, Kimura T, de Alboran IM, Nakayama K et al. (2007). Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis. J Exp Med 204: 2875–2888.
Radtke F, Raj K . (2003). The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer 3: 756–767.
Ramain P, Khechumian K, Seugnet L, Arbogast N, Ackermann C, Heitzler P . (2001). Novel Notch alleles reveal a Deltex-dependent pathway repressing neural fate. Curr Biol 11: 1729–1738.
Rangarajan A, Talora C, Okuyama R, Nicolas M, Mammucari C, Oh H et al. (2001). Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J 20: 3427–3436.
Ruel L, Bourouis M, Heitzler P, Pantesco V, Simpson P . (1993). Drosophila shaggy kinase and rat glycogen synthase kinase-3 have conserved activities and act downstream of Notch. Nature 362: 557–560.
Sarmento LM, Huang H, Limon A, Gordon W, Fernandes J, Tavares MJ et al. (2005). Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27 Kip1 degradation. J Exp Med 202: 157–168.
Strohmaier H, Spruck CH, Kaiser P, Won KA, Sangfelt O, Reed SI . (2001). Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 413: 316–322.
Sundaram M, Greenwald I . (1993). Suppressors of a lin-12 hypomorph define genes that interact with both lin-12 and glp-1 in Caenorhabditis elegans. Genetics 135: 765–783.
Sundqvist A, Bengoechea-Alonso MT, Ye X, Lukiyanchuk V, Jin J, Harper JW et al. (2005). Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCF(Fbw7). Cell Metab 1: 379–391.
Tetzlaff MT, Yu W, Li M, Zhang P, Finegold M, Mahon K et al. (2004). Defective cardiovascular development and elevated cyclin E and Notch proteins in mice lacking the Fbw7 F-box protein. Proc Natl Acad Sci USA 101: 3338–3345.
Thompson BJ, Buonamici S, Sulis ML, Palomero T, Vilimas T, Basso G et al. (2007). The SCF(FBW7) ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J Exp Med 204: 1825–1835.
Tsunematsu R, Nakayama K, Oike Y, Nishiyama M, Ishida N, Hatakeyama S et al. (2004). Mouse Fbw7/Sel-10/Cdc4 is required for notch degradation during vascular development. J Biol Chem 279: 9417–9423.
Wei W, Jin J, Schlisio S, Harper JW, Kaelin Jr WG . (2005). The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase. Cancer Cell 8: 25–33.
Welcker M, Clurman BE . (2008). FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 8: 83–93.
Welcker M, Orian A, Jin J, Grim JE, Harper JW, Eisenman RN et al. (2004). The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci USA 101: 9085–9090.
Weng AP, Millholland JM, Yashiro-Ohtani Y, Arcangeli ML, Lau A, Wai C et al. (2006). c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev 20: 2096–2109.
Yada M, Hatakeyama S, Kamura T, Nishiyama M, Tsunematsu R, Imaki H et al. (2004). Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J 23: 2116–2125.
Yang X, Klein R, Tian X, Cheng HT, Kopan R, Shen J . (2004). Notch activation induces apoptosis in neural progenitor cells through a p53-dependent pathway. Dev Biol 269: 81–94.
Zweidler-McKay PA, He Y, Xu L, Rodriguez CG, Karnell FG, Carpenter AC et al. (2005). Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies. Blood 106: 3898–3906.
Acknowledgements
We thank T Honjo for RbpjF/F mice; R Tsunematsu for an NICD1 plasmid; T Kitamura for pMX-puro and Plat-E cells; Y Ono and N Kobayashi for technical assistance; N Ishida and other laboratory members for helpful discussion. This study was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the 21st Century Center of Excellence Program.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)
Supplementary information
Rights and permissions
About this article
Cite this article
Ishikawa, Y., Onoyama, I., Nakayama, K. et al. Notch-dependent cell cycle arrest and apoptosis in mouse embryonic fibroblasts lacking Fbxw7. Oncogene 27, 6164–6174 (2008). https://doi.org/10.1038/onc.2008.216
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2008.216
Keywords
This article is cited by
-
Temperature sensitivity of Notch signaling underlies species-specific developmental plasticity and robustness in amniote brains
Nature Communications (2022)
-
Long non-coding RNA MEG3 inhibits cervical cancer cell growth by promoting degradation of P-STAT3 protein via ubiquitination
Cancer Cell International (2019)
-
The role of FBXW7, a cell-cycle regulator, as a predictive marker of recurrence of gastrointestinal stromal tumors
Gastric Cancer (2019)
-
Emerging roles of Myc in stem cell biology and novel tumor therapies
Journal of Experimental & Clinical Cancer Research (2018)
-
FADD regulates thymocyte development at the β-selection checkpoint by modulating Notch signaling
Cell Death & Disease (2014)